KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1

Abstract Kruppel-Like Factor 13 (KLF13) has strong effects on cancer occurrence and progression. Nevertheless, the role of KLF13 in oesophagal cancer (EC) remain elusive. In this study, we detected the expression of KLF13 in EC tissues and cells using immunohistochemistry, western blot, and real-tim...

Full description

Saved in:
Bibliographic Details
Main Authors: Pengjie Yang, Benben Zhu, Hongwei Cui, Yongjun Yu, Qin Yu, Linghui Kong, Mengfei Sun, Yuan Liu, Bateer Han, Shuchen Chen
Format: Article
Language:English
Published: Nature Publishing Group 2025-05-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07709-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850243112982544384
author Pengjie Yang
Benben Zhu
Hongwei Cui
Yongjun Yu
Qin Yu
Linghui Kong
Mengfei Sun
Yuan Liu
Bateer Han
Shuchen Chen
author_facet Pengjie Yang
Benben Zhu
Hongwei Cui
Yongjun Yu
Qin Yu
Linghui Kong
Mengfei Sun
Yuan Liu
Bateer Han
Shuchen Chen
author_sort Pengjie Yang
collection DOAJ
description Abstract Kruppel-Like Factor 13 (KLF13) has strong effects on cancer occurrence and progression. Nevertheless, the role of KLF13 in oesophagal cancer (EC) remain elusive. In this study, we detected the expression of KLF13 in EC tissues and cells using immunohistochemistry, western blot, and real-time PCR, and found that KLF13 was upregulated in EC tissues and cells compared to normal controls. High expression of KLF13 indicated a poor prognosis for EC patients. Further, function studies in vitro and in vivo were performed to explore the role of KLF13 in EC cell progression. The results revealed that KLF13 knockdown suppressed EC cell proliferation, migration, epithelial-mesenchymal transition, increased cell apoptosis and cell cycle arrest in vivo and inhibited tumour growth in vitro. Conversely, KLF13 overexpression in EC cells had the opposite consequences. Mechanically, differentially expressed genes downstream of KLF13 were identified by RNA-seq and ChIP-seq. We found that there is a positive correlation between triacylglyceride and free fatty acid levels and KLF13 expression levels. A lipid-related gene, Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 (GPIHBP1), was identified as a downstream gene of KLF13 using luciferase and chromatin immunoprecipitation assays, whose expression was positively regulated by KLF13. Finally, in vitro and in vivo recovery assays using shRNAs and overexpression plasmids confirmed that KLF13 has an oncogenic role in EC progression through GPIHBP1. Collectively, KLF13 can promote EC progression, triacylglyceride and free fatty acid metabolism through GPIHBP1. Therefore, molecular therapies targeting KLF13 and GPIHBP1 may be effective treatments against EC.
format Article
id doaj-art-a2b9951bd3bc45d99312a62f6dff4cd9
institution OA Journals
issn 2041-4889
language English
publishDate 2025-05-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-a2b9951bd3bc45d99312a62f6dff4cd92025-08-20T02:00:06ZengNature Publishing GroupCell Death and Disease2041-48892025-05-0116111210.1038/s41419-025-07709-7KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1Pengjie Yang0Benben Zhu1Hongwei Cui2Yongjun Yu3Qin Yu4Linghui Kong5Mengfei Sun6Yuan Liu7Bateer Han8Shuchen Chen9Department of Thoracic Surgery, Fujian Medical University Union HospitalDepartment of Pharmacy, Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical UniversityScientific Research Department, Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical UniversityDepartment of Thoracic Surgery, Inner Mongolia Medical UniversityDepartment of Radiotherapy, Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical UniversityDepartment of Pathology, Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical UniversityCollege of Pharmacy, Inner Mongolia Medical UniversityDepartment of integrated Chinese and Western medicine, Inner Mongolia Mental Health Center, Third Hospital of Inner Mongolia Autonomous RegionDepartment of Thoracic Surgery, Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical UniversityDepartment of Thoracic Surgery, Fujian Medical University Union HospitalAbstract Kruppel-Like Factor 13 (KLF13) has strong effects on cancer occurrence and progression. Nevertheless, the role of KLF13 in oesophagal cancer (EC) remain elusive. In this study, we detected the expression of KLF13 in EC tissues and cells using immunohistochemistry, western blot, and real-time PCR, and found that KLF13 was upregulated in EC tissues and cells compared to normal controls. High expression of KLF13 indicated a poor prognosis for EC patients. Further, function studies in vitro and in vivo were performed to explore the role of KLF13 in EC cell progression. The results revealed that KLF13 knockdown suppressed EC cell proliferation, migration, epithelial-mesenchymal transition, increased cell apoptosis and cell cycle arrest in vivo and inhibited tumour growth in vitro. Conversely, KLF13 overexpression in EC cells had the opposite consequences. Mechanically, differentially expressed genes downstream of KLF13 were identified by RNA-seq and ChIP-seq. We found that there is a positive correlation between triacylglyceride and free fatty acid levels and KLF13 expression levels. A lipid-related gene, Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 (GPIHBP1), was identified as a downstream gene of KLF13 using luciferase and chromatin immunoprecipitation assays, whose expression was positively regulated by KLF13. Finally, in vitro and in vivo recovery assays using shRNAs and overexpression plasmids confirmed that KLF13 has an oncogenic role in EC progression through GPIHBP1. Collectively, KLF13 can promote EC progression, triacylglyceride and free fatty acid metabolism through GPIHBP1. Therefore, molecular therapies targeting KLF13 and GPIHBP1 may be effective treatments against EC.https://doi.org/10.1038/s41419-025-07709-7
spellingShingle Pengjie Yang
Benben Zhu
Hongwei Cui
Yongjun Yu
Qin Yu
Linghui Kong
Mengfei Sun
Yuan Liu
Bateer Han
Shuchen Chen
KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1
Cell Death and Disease
title KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1
title_full KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1
title_fullStr KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1
title_full_unstemmed KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1
title_short KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1
title_sort klf13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through gpihbp1
url https://doi.org/10.1038/s41419-025-07709-7
work_keys_str_mv AT pengjieyang klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT benbenzhu klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT hongweicui klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT yongjunyu klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT qinyu klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT linghuikong klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT mengfeisun klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT yuanliu klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT bateerhan klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1
AT shuchenchen klf13promotesesophagealcancerprogressionandregulatestriacylglycerideandfreefattyacidmetabolismthroughgpihbp1